Echocardiography variables predictive of appropriate therapies for ventricular tachyarrhythmia in patients undergoing combined cardiac resynchronization therapy;Variáveis ecocardiográficas predizentes de terapêuticas apropriadas de taquidisritmias ventriculares em doentes submetidos a terapêutica de ressincronização cardíaca combinada

Revista Portuguesa de Cardiologia

Volumn 29, Issue 6, 2010, Pages 1009-1019

  Timóteo, Ana Teresa ^a   Galrinho, Ana ^a   Branco, Luísa Moura ^a   Oliveira, Mário Martins ^a   Da Silva, Manuel Nogueira ^a   Feliciano, Joana ^a   Soares, Rui ^a   Cunha, Pedro Silva ^a   Leal, Ana ^a   Santos, Sofia ^a   Ferreira, Rui Cruz ^a  

^a HOSPITAL DE SANTA MARTA   (Portugal)

Author keywords

Appropriate therapies; Cardiac resynchronization therapy; Dilated cardiomyopathy; Echocardiography; Implantable cardioverter defibrillator

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANTATION; MALE; PREDICTION; TISSUE DOPPLER IMAGING; ECHOGRAPHY; MIDDLE AGED; PREDICTIVE VALUE; RETROSPECTIVE STUDY;

CARDIAC RESYNCHRONIZATION THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR;

EID: 77957709694     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. The Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from near-fatal ventricular arrhythmia. N Engl J Med. 1997; 337: 1576-83.
2. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML. Analysis of mortality events in the MADIT-II trial. J Am Coll Cardiol. 2004; 43: 1459-65.
3. Cowie M, Mostard A, Wood D, Deckers J, Poole-Wilson P, Sutton G. The epidemiology of heart failure. Eur Heart J. 1997; 18: 208-23.
4. Abraham WT, Fisher WG, Smith AL, et al., for the MIRACLE Study Group. Multicenter InSync Randomized Clinical Evaluation. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002; 346: 1845-53.
5. Bank AJ, Kaufman CL, Kelly AS, et al. Results of the PROspective Minnesota Study of ECHO/TDI in Cardiac Resynchronization Therapy (PROMISE-CRT) Study. J Cardiac Fail. 2009; 15: 401-9.
6. Varcas PE, Auricchio A, Blanc JJ, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2007; 28: 2256-95.
7. Lin G, Rea RF, Hammill SC, Hayes DL, Brady PA. Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillator undergoing upgrade to cardiac resynchronisation therapy device. Heart. 2008; 94: 186-90. (Pubitemid 351211727)
8. Lepillier A, Piot O, Gerritse B, et al. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronisation plus defibrillator. Europace. 2009; 11: 80-5.
9. Di Biase L, Gasparini M, Lunati M, et al. Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the Insync ICD Implantable Cardioverter-Defibrillator Italian Registry. J Am Coll Cardiol. 2008 52: 1442-9.
10. Cleland J, Daubert J, Erdmann E, et al. Long-term effects of cardiac resynchronization therapy on mortality in heart failure (the CArdiac REsynchronization-Heart Failure - CARE-HF - trial extension phase). Eur Heart J 2006; 27: 1928-32.